China National Accord Medicines Balance Sheet Health
Financial Health criteria checks 5/6
China National Accord Medicines has a total shareholder equity of CN¥21.7B and total debt of CN¥4.3B, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are CN¥52.0B and CN¥30.3B respectively. China National Accord Medicines's EBIT is CN¥1.9B making its interest coverage ratio -29. It has cash and short-term investments of CN¥5.4B.
Key information
19.9%
Debt to equity ratio
CN¥4.30b
Debt
Interest coverage ratio | -29x |
Cash | CN¥5.43b |
Equity | CN¥21.65b |
Total liabilities | CN¥30.33b |
Total assets | CN¥51.98b |
Recent financial health updates
Here's Why China National Accord Medicines (SZSE:000028) Can Manage Its Debt Responsibly
Jan 22China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly
Oct 10Is China National Accord Medicines (SZSE:000028) A Risky Investment?
Jun 12China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet
Feb 29Recent updates
Here's Why China National Accord Medicines (SZSE:000028) Can Manage Its Debt Responsibly
Jan 22Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E
Nov 18China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Oct 30China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly
Oct 10China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement
Aug 13Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)
Jul 12Is China National Accord Medicines (SZSE:000028) A Risky Investment?
Jun 12Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet
May 12Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results
Apr 10China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate
Mar 15China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet
Feb 29Financial Position Analysis
Short Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its short term liabilities (CN¥28.1B).
Long Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its long term liabilities (CN¥2.2B).
Debt to Equity History and Analysis
Debt Level: 000028 has more cash than its total debt.
Reducing Debt: 000028's debt to equity ratio has increased from 16.2% to 19.9% over the past 5 years.
Debt Coverage: 000028's debt is well covered by operating cash flow (64%).
Interest Coverage: 000028 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/06 04:11 |
End of Day Share Price | 2025/02/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China National Accord Medicines Corporation Ltd. is covered by 25 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Lei Tian | AJ Securities Co., Ltd |
Shuchang Liu | Changjiang Securities Co. LTD. |
Yanyin Zhu | China International Capital Corporation Limited |